Oduselu Gbolahan O, Ajani Olayinka O, Ogunnupebi Temitope A, Elebiju Oluwadunni F, Bodun Damilola S, Opebiyi Oluwabukayo Toluwunmiju, Adebiyi Ezekiel
Covenant University Bioinformatics Research (CUBRe), Covenant University Ota Nigeria
West African Centre for Cell Biology of Infectious Pathogens (WACCBIP), University of Ghana P. O Box LG 54, Legon Accra Ghana.
RSC Med Chem. 2025 Mar 19. doi: 10.1039/d5md00114e.
Amidoximes are employed as building blocks to synthesise heterocyclic motifs with biological significance. They are very reactive and are used as prodrugs of amidine. This present study unveils the synthesis of amidoxime-based benzimidazole and benzimidamide motifs and evaluates their and antimicrobial potential as future drug candidates. The compounds (2a, 2b, 4a-c) were synthesized using multi-step synthetic pathways. The synthesised compounds were characterised using physico-chemical examination, H- and C-NMR, DEPT-135, and FT-IR spectroscopic analyses. The antimicrobial potentials of the synthesized compounds were carried out against glucosamine-6-phosphate synthase of (PDB ID: 2VF5), and -myristoyltransferase (NMT) of (PDB ID: 1IYL), while the antimicrobial screening was investigated against selected bacteria and fungi. The studies were carried out using predicted ADMET screening, molecular docking, MM-GBSA, induced-fit docking (IFD), and molecular dynamics (MD) simulation studies. Furthermore, the experimental validations were performed using the agar diffusion method and the standard antibacterial and antifungal drugs used were gentamicin and ketoconazole respectively. The predicted toxicity test of the compounds showed no significant risk, except for 4c, which showed high tumorigenic risk. Compounds 2b and 2a gave better binding energies; -8.0 kcal mol for 2VF5 and -11.7 kcal mol for 1IYL, respectively. The antimicrobial zone of inhibition and minimum inhibitory concentration values were 40 mm and 3.90 mg mL against , then 42 mm and 1.90 mg mL against . Potential antimicrobial drug candidates have been identified in this report and should be explored for future preclinical research.
偕胺肟被用作合成具有生物学意义的杂环基序的构建单元。它们反应性很强,用作脒的前药。本研究揭示了基于偕胺肟的苯并咪唑和苯并咪唑酰胺基序的合成,并评估了它们作为未来药物候选物的抗菌潜力。化合物(2a、2b、4a - c)通过多步合成途径合成。使用物理化学检测、H 和 C - NMR、DEPT - 135以及FT - IR光谱分析对合成的化合物进行了表征。对合成化合物的抗菌潜力针对大肠杆菌的6 - 磷酸氨基葡萄糖合酶(PDB ID:2VF5)和酿酒酵母的N - 肉豆蔻酰转移酶(NMT)(PDB ID:1IYL)进行了测试,同时针对选定的细菌和真菌进行了抗菌筛选。使用预测的ADMET筛选、分子对接、MM - GBSA、诱导契合对接(IFD)和分子动力学(MD)模拟研究进行了研究。此外,使用琼脂扩散法进行了实验验证,使用的标准抗菌和抗真菌药物分别是庆大霉素和酮康唑。化合物的预测毒性测试显示除4c显示出高致癌风险外,没有显著风险。化合物2b和2a给出了更好的结合能;分别为针对2VF5的 - 8.0 kcal/mol和针对1IYL的 - 11.7 kcal/mol。对大肠杆菌的抑菌圈和最低抑菌浓度值分别为40 mm和3.90 mg/mL,对金黄色葡萄球菌则为42 mm和1.90 mg/mL。本报告中已鉴定出潜在的抗菌药物候选物,应在未来的临床前研究中进行探索。